Up‐regulation of YAP1 has been observed in gastric cancer, colorectal cancer, squamous cell carcinoma (SCC), non‐small cell lung cancer (NSCLC), ovarian cancer, uveal melanoma, endometrial cancer, hepatocellular cancer (HCC), pancreatic ductal adenocarcinoma, cholangiocarcinoma, and head and neck cancer 9, 82, 84, 90, 91, 92, 93, 94, 95, 96. Here, YAP1 is linked to non-small cell lung carcinoma.